Description
In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents.
In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.
Links:
Bold predictions for healthcare in 2024
What you need to know about rising medical group consolidation
Physician employment is changing. What does that mean for the industry?
Ep. 198: PE firm General Catalyst is buying a hospital — here's our take
Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others.
Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities.
Learn more about Advisory Board Fellowship.
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Last week on Radio Advisory, we broke down what healthcare leaders need to know for 2025 and beyond following the recent elections. But before we move on from 2024 completely, we have to acknowledge that there’s been a lot moving in the policy space this year, and frankly, there have probably...
Published 11/19/24
(Note: This episode was recorded on November 7, 2024)
The results of the 2024 elections are in: Donald Trump will be the 47th President of the United States, and we are all but certain to have a Republican trifecta at the federal level. Admittedly, there’s a lot we don’t know about what...
Published 11/12/24